A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1111/bph.16141
dc.identifier.other
WOS:001063394800001
dc.description.volume
dc.description.issue
Publisher
WILEY
DOI
10.1111/bph.16141